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Circulating Endothelial Progenitor Cells as a New Marker
of Endothelial Dysfunction or Repair in Acute Stroke
Kon Chu, MD, PhD; Keun-Hwa Jung, MD; Soon-Tae Lee, MD; Hee-Kwon Park, MD;
Dong-In Sinn, MD; Jeong-Min Kim, MD; Dong-Hyun Kim, MS; Jin-Hee Kim, MS;
Se-Jeong Kim, MS; Eun-Cheol Song, MD; Manho Kim, MD, PhD; Sang Kun Lee, MD, PhD;
Jae-Kyu Roh, MD, PhD
Background and Purpose—Understanding on distinct subsets of endothelial progenitor cells may provide insights of
endothelial dysfunction or repair in the acute ischemic event. Recent in vitro data have reported the colony-forming unit
(CFU) and outgrowth cell population as a subset of endothelial progenitor cells. In this study, we undertook to validate
the significance of CFU number and outgrowth cell yield in acute stroke.
Methods—Mononuclear cells were isolated from the peripheral blood of 75 patients with acute stroke, 45 patients with
chronic stroke, and 40 age-matched healthy volunteers. CFU numbers were counted after culturing them for 7 days, and
outgrowth cell appearance was measured during the 2 months of culture. Endothelial progenitor cell function was also
evaluated by matrigel plate assays. Independent parameters predicting CFU number and outgrowth cell yield were
assessed using logistic regression analysis.
Results—The CFU numbers and tube formation abilities in matrigel assays were significantly reduced in patients with
acute stroke compared with patients with chronic stroke or healthy control subjects. Moreover, patients with large artery
atherosclerosis had much lower CFU numbers and functional activities than ones with cardioembolism. Outgrowth cells
were isolated from 10% of healthy control subjects and 22% of patients with chronic stroke during the cultures, but from
71% of patients with stroke. Multivariate analysis identified glycosylated hemoglobin and National Institutes of Health
Stroke Scale on admission as significant independent predictors of a low CFU number and a high isolation frequency
of outgrowth cells, respectively.
Conclusion—CFU number may thus represent an accumulated endothelial progenitor cell dysfunctional status, whereas
outgrowth cell appearance may reflect the resilience of the systemic circulation to acute ischemic stress. (Stroke. 2008;
39:1441-1447.)
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Endothelial progenitor cells (EPCs) constitute a circulat-ing pool of cells that counteract ongoing risk factor-
induced endothelial cell injury and replace dysfunctional
endothelium.1 Recent studies have demonstrated that an
accumulation of cardiovascular risk factors and the presence
of coronary, cerebral, or peripheral atherosclerosis are asso-
ciated with dysfunction and reduced numbers of endothelial
progenitor cells.1–6 Moreover, a low EPC level has been
shown to be an independent risk factor of future cardiovas-
cular events.7,8 On the other hand, EPCs are mobilized from
bone marrow during acute ischemia and contribute to the
neovascularization of ischemic tissues.9–13 Limb ischemia
and acute myocardial infarction have been associated with a
rapid increase in circulating EPC numbers, and vascular traumas
such as coronary bypass grafting or burn injury are also
suggested as inducing the rapid transient mobilization of
EPCs.11–13 Thus, EPC levels must be carefully interpreted in the
combined setting of acute ischemia and chronic vascular insult.
Unlike acute coronary syndrome, which has many nonspe-
cific and specific plasma or serum markers that may be used
to both diagnose and assess the severity of myocardial
infarction, no similar established markers exist for patients
with stroke. Biological assays of EPCs may allow clinicians
to demonstrate the specific mechanisms of ischemic lesions
and to predict their severities and courses. Furthermore, after
cerebral ischemia, neovascularization and new vessel growth
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occur in ischemic areas.14 New endothelial cells in the setting
of ischemia are partly derived from circulating EPCs of bone
marrow origin. Thus, the isolation of circulating EPCs may help
in the development of EPC-based cell therapies in stroke.
However, data on the biology of circulating EPCs at the acute
stage in subjects with stroke are sparse. In fact, only one study
has reported reduced number of colonies of cultured circulating
EPCs in acute and stable patients with stroke.6
Our understanding of the growing number of reports on
EPC biology has been hampered by a lack of corroborated
methods than can precisely identify EPCs. Whereas some
investigators have used flow cytometry as a means of
estimating EPC levels,2,7,13 others refer to colony-forming
units (CFUs).1,6 As the number of circulating EPCs represents
a dynamic balance between production induced by chronic or
acute stimuli and consumption in damaged areas, studies by
flow cytometry at limited time points during acute ischemia
are of limited usefulness. Emerging evidence indicates that
CFU number more appropriately represents EPC functional
properties rather than EPC number.1,2,15 Whereas EPC func-
tion is critical for endothelial maintenance and repair, CFU
number may indicate a cumulative vascular risk in ischemia.
On the other hand, EPCs constitute a heterogenous population
with distinct growth characteristics. This problem of hetero-
geneity is confounded by the different names used, ie,
endothelial outgrowth cells, circulating angiogenic cells, and
endothelial-like cells, given to possibly overlapping cell
types.16–20 The cell population outgrown from the long-term
cultures may be a subset of true EPCs derived from bone
marrow with the potential for vascular repair after injury.18–20
However, to date, no study has validated that outgrowth cell
yield is a potential marker of circulating EPC levels. In the
present article, a simple yet precise method was used to count
CFUs and to observe the appearance of outgrowth cells,
which represents a modest first approach in this subject area.
In addition, we attempted to identify factors associated with
EPC parameters in the setting of acute stroke.
Methods
Study Population
Eligible patients (age, 30 to 70 years) with a clinically and radio-
logically proven first ischemic stroke and admitted to the Department
of Neurology, Seoul National University Hospital were recruited
consecutively. As a control group, age- and sex-matched healthy
subjects, free from atherothrombotic or hematologic disease, were
selected from volunteers. In addition, age- and sex-matched patients
with a stroke history (3 months before the recruitment) were
selected from patients referred to the outpatient clinic of the
Department of Neurology. The total study population included 75
patients with acute stroke, 45 patients with chronic stroke, and 40
healthy subjects; and their demographic and medical data were
collected as described in the online supplementary methods. The
study protocol was approved by the Scientific Review Committee
and the Institutional Review Board of Seoul National University
Hospital and all enrolled subjects provided written informed consent
as required by the Declaration of Helsinki.
Isolation and Culture of Peripheral Blood-Derived
Mononuclear Cells
After obtaining informed consent, peripheral blood was sampled
from patients 5 to 7 days after symptom onset (6.94.7 days). Total
human of peripheral blood-derived mononuclear cells (PB-MNCs)
were isolated from 50 mL of blood from each of the 160 enrolled
subjects by density gradient centrifugation using Histopaque-1077
(Sigma, St Louis, Mo) as described previously19,20 and online
supplementary methods.
Colony-Forming Unit Counts
CFUs were defined as a central core of rounded cells surrounded by
elongating and spindle-shaped cells and were counted after 7 days in
culture. Cell clusters alone without emerging spindle cells were not
counted as positive. Colonies were counted manually in a minimum
of 3 wells of each 12-well plate by 2 independent observers who
were unaware of clinical profiles, and results were expressed as
average numbers of CFUs per well. In selected samples, the
endothelial phenotype was confirmed using endothelial-specific
indicators, ie, uptake of DiI-LDL, staining for UEA-1 lectin, CD31,
VE-cadherin, CD34, and KDR, as previously reported.16–20
Matrigel Plate Assay
In selected subjects (n6 per group), angiogenic activities of
conditioned media were assessed using Matrigel plates (BD Bio-
sciences, Bedford, Mass) and human umbilical vein endothelial cells
(HUVECs). Conditioned media were obtained by replacing the
media of 4-day MNC cultures with serum-free endothelial basal
media (EBM; Clonetics, Baltimore, Md) supplemented with EGM-2
single aliquots (growth factors like vascular endothelial growth
factor and fibroblast growth factor-2 were omitted), and cells were
then cultured for an additional 72 hours. HUVECs grown overnight
in EBM were treated with trypsin and resuspended in EBM. The
wells of 96-well tissue culture plates were coated with Matrigel (0.04
mL/well), which was left to solidify for 1 hour at 37°C. HUVECs
(15 000 in 0.15 mL EBM) were then added to each well. Conditioned
media (200 L) were added to these HUVECs (in sextuplicate) and
16 hours later, media were removed. The cells were then fixed, and
the lengths of structures resembling capillaries were measured over
whole well areas using Image-Pro Plus (Media Cybernetics, Silver
Spring, Md). The total length of tube networks was expressed
as mm/mm2, and the total area of complete tubes formed by cells was
expressed as mm2/mm2.
Statistical Analysis
All data in this study are expressed as meansSD. The 3 study
populations and the stroke subtypes were compared in terms of the
following variables: background characteristics (age, gender, Na-
tional Institutes of Health Stroke Scale [NIHSS], infarct location),
risk factors (hypertension, diabetes mellitus, atrial fibrillation, dys-
lipidemia, smoking), and culture parameters (CFU number, out-
growth cell yield). Continuous variables were tested for normal
distribution using the Kolmogorov-Smirnov test. Comparisons be-
tween groups were analyzed using the 2-tailed unpaired Student t test
or analysis of variance followed by Tukey’s test for normally
distributed variables and using the Kruskal-Wallis test for nonnor-
mally distributed variables. Categorical variables were compared
using the Pearson 2 test. Correlations between 2 continuous vari-
ables were performed using Spearman’s rank correlation coeffi-
cients. Next, univariate associations between specific parameters and
CFU counts and outgrowth cell yields were assessed. The dependent
variables were the CFU counts and outgrowth cell appearance, and
the independent variables considered were patient age, gender,
hypertension, diabetes mellitus, dyslipidemia, smoking status, and a
variety of radiological and laboratory values. To identify indepen-
dent determinants of CFU number and outgrowth cell yield in the
patients with acute stroke, multivariate logistic regression analysis
was performed for various clinical, radiological, and laboratory
parameters. Probability values of 0.05 were regarded as being
statistically significant. SPSS software (SPSS 12.0; SPSS Inc,
Chicago, Ill) was used for the analyses.
Results
Study Population Demographics
The baseline characteristics of the 160 study subjects are
summarized in Table 1. CFU and outgrowth cells were
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derived from PB-MNC cultures (Supplemental Figure I,
available online at http://stroke.ahajournals.org). CFU num-
bers were significantly lower in patients with acute stroke
than in patients with chronic stroke and healthy subjects
(21.316.5 versus 50.727.4 and 72.424.5, P0.001,
analysis of variance). Outgrowth cells were only isolated
from 4 (10.0%) and 10 (22.2%) of 40 healthy subjects and 45
subjects with chronic stroke, respectively, but were readily
isolated from 53 (70.7%) of the 75 patients with stroke
(P0.001, Pearson 2 test).
Characteristics of Stroke Subpopulations
Subjects with stroke were divided into 4 subgroups based on
stroke etiology. Of the 75 consecutive patients with stroke
recruited, 25 (33.3%) patients were allocated to the large
artery atherosclerosis (LAA) group, 18 (24.0%) to the car-
dioembolism (CE) group, 23 to the small vessel occlusion
(SVO; 30.7%), and the 9 to the intracerebral hemorrhage
(ICH; 12.0%); these groups were compared in terms of the
following variables: background characteristics (age, gender,
NIHSS), risk factors (hypertension, diabetes mellitus, heart
disease, dyslipidemia, smoking), radiological data (lesion
volumes), and culture outcome data (CFU, outgrowth cell
yield). As shown in Table 2, these 4 groups did not differ with
respect to age, gender, dyslipidemia, or smoking. Hyperten-
sion was more common in patients with LAA, SVO, and ICH
than in those with CE; nearly 60% of patients with LAA and
SVO had hypertension. Atrial fibrillation was more prevalent
in the CE group. The SVO group had milder neurological
deficits and smaller infarct volumes than the other 2 groups,
and the CE group had more severe neurological deficits at the
time of stroke. We also examined whether these 4 stroke
subtypes was associated with culture outcomes, CFU number,
and outgrowth cell isolation. The CE group had significantly
higher CFU numbers (34.013.5) than the LAA (14.58.5),
SVO (18.317.5), and ICH groups (22.523.4; P0.001,
analysis of variance followed by Tukey’s test). Outgrowth
cells tended to be more frequently observed in the CE and
LAA groups than in the other 2 groups, but this was not
significant.
Matrigel Tube Assay in the Ischemic
Stroke Subpopulations
To investigate whether the paracrine functions of CFU-
derived cells are differentially affected by ischemic stroke
subtype, we examined the angiogenic potentials of their
conditioned media using Matrigel assays. HUVECs were
seeded on Matrigel matrices in the conditioned media of
CFU-derived cells from patients with stroke overnight (n6
for each stroke subtype) or from healthy subjects (n6).
Conditioned media from healthy subjects markedly stimu-
lated tube formation as compared with nonconditioned media







Age 58.411.0 61.59.6 63.111.6 0.763
Sex, male (%) 25 (62.5) 28 (62.2) 48 (63.0) 0.575
Hypertension (%) 0 28 (62.2) 41 (54.7) 0.001*
Diabetes mellitus (%) 0 18 (40.0) 24 (32.4) 0.004*
Dyslipidemia (%) 0 9 (20.0) 14 (18.9) 0.019*
Current smoking (%) 6 (15.0) 16 (35.5) 28 (37.3) 0.106
Atrial fibrillation (%) 0 8 (17.7) 22 (29.7) 0.020*
CFU 72.424.5 50.727.4 21.316.5 0.001*
Isolation of outgrowth cells (%) 4 (10.0) 10 (22.2) 53 (70.7) 0.000*
*P0.05, Pearson 2 test or analysis of variance followed by Tukey’s test.
Table 2. Characteristics of the Acute Stroke Subpopulations
LAA (n25) CE (n18) SVO (n23) ICH (n9) P Value
Age 60.812.2 67.211.4 61.18.9 67.114.8 0.197
Sex, male (%) 17 (68.0) 12 (66.7) 12 (52.2) 7 (77.8) 0.500
Hypertension (%) 14 (56.0) 5 (27.8) 15 (65.2) 7 (77.8) 0.173
Diabetes mellitus (%) 11 (44.0) 3 (16.7) 7 (30.4) 3 (37.5) 0.295
Dyslipidemia (%) 5 (20.0) 3 (16.7) 4 (17.4) 2 (22.2) 0.951
Current smoking (%) 11 (44.0) 4 (22.2) 3 (13.0) 0 0.218
Atrial fibrillation (%) 0 15 (83.3) 2 (8.7) 0 0.000*
CFU 14.58.5 34.013.5 18.317.5 22.523.4 0.001*
Isolation of outgrowth cells (%) 18 (72.0) 15 (83.3) 14 (60.9) 6 (66.7) 0.730
Initial NIHSS 4.74.5 7.86.4 1.32.7 5.13.7 0.025*
Lesion volume, cm3 22.242.7 26.141.5 1.20.5 22.317.4 0.063
*P0.05, Pearson 2 test or analysis of variance followed by Tukey’s test.
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(EBM), demonstrating that CFU-derived cells can facilitate
angiogenesis in a paracrine fashion, or alternatively, that cul-
tured MNCs from patients with stroke secrete factors that impair
angiogenesis in vitro (Figure A–D). As shown in Figures E and
F, a detailed analysis of CFU-derived cell functionality versus
stroke subtype revealed higher values for complete tube area and
total tube length in the CE group than in the LAA and SVO
groups (complete tube area: 0.310.10 versus 0.120.07 and
0.130.09 mm2/mm2; total tube length: 5.700.54 versus
4.350.67 and 3.980.18 mm/mm2, respectively).
Predictors for Lower Colony-Forming Unit
Number in Patients With Acute Stroke
To identify the factors that affect CFU number in the setting
of acute stroke, the clinical, radiological, and laboratory
parameters were analyzed for correlations with CFU levels
and compared in low CFU (10 CFU) and intermediate CFU
groups (10 CFU). CFU levels tended to decline linearly
with advancing age and higher glycosylated hemoglobin
(HbA1c), but this tendency did not reach statistical signifi-
cance (age: r0.104, P0.180; HbA1c: r0.179,
P0.203). Age, HbA1c, and homocysteine levels (at admis-
sion) were higher in the low CFU group than in the interme-
diate CFU (age: 65.79.9 versus 61.912.6; HbA1c:
6.81.6 versus 5.80.6; homocysteine: 14.56.8 versus
9.15.7, respectively). No significant differences were found
in the initial NIHSS, infarct volumes, lacunes, microbleeds,
C-reactive protein, cholesterol, high-density lipoprotein, or
low-density lipoprotein between the low CFU and interme-
Figure. Matrigel plate assays in the 3 stroke subpopulations. Cultures of PB-MNCs were used to condition media for 3 days, and con-
ditioned media were added to HUVECs on Matrigel-coated 96-well plates. Representative photomicrographs show the formation of
tube-like structures in healthy control subjects (A) and 3 distinct stroke subpopulations (B: LAA; C: CE; D: SVO). Complete tube areas
(E) and total tube network lengths (F) were determined by Matrigel assays. Results are expressed as meansSD; n6 for each group;
*P0.05 versus healthy control subjects; #P0.05 versus the LAA group.
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diate CFU groups (Table 3). By univariate analysis, 4
variables were found to significantly differentiate patients
with a low CFU number from those with an intermediate
CFU: age (P0.006), diabetes mellitus (P0.002), HbA1c
(P0.008), and homocysteine (P0.032). All variables
shown in Table 3 were initially entered into a logistic
regression model, and the least significant variables were
removed from the model in a stepwise fashion. Table 4 shows
the adjusted ORs of variables for independently predicting
CFU levels. Multivariate analysis showed that only HbA1c
significantly and independently predicted CFU numbers.
Predictors of Outgrowth Cell Generation in
Patients With Acute Stroke
To identify factors that predict the outgrowth cell appearance
in the setting of acute stroke, we categorized patients into 2
groups: outgrowth cell-negative and -positive groups. NIHSS
scores, infarct volumes, and C-reactive protein on admission
were greater in the outgrowth cell-positive group than in
the outgrowth cell-negative group (NIHSS: 2.73.0 versus
6.05.0, P0.005; infarct volume: 7.511.7 versus
22.538.8 cm3, P0.029; C-reactive protein: 0.50.8
versus 1.82.5, P0.044). However, the 2 groups were
similar in terms of age, lacunes, microbleeds, HbA1c, homo-
cysteine, cholesterol, high-density lipoprotein, and low-
density lipoprotein levels (Table 5). All variables shown in
Table 5 were entered into a logistic regression model, and
again, most insignificant variables were removed in a step-
wise fashion. Table 6 shows the adjusted ORs of independent
variables for predicting outgrowth cell appearance. Multivar-
Table 3. Factors Associated With the CFU Numbers of





Age 65.79.9 61.912.6 0.006*
Hypertension (%) 18 (62.1) 23 (50.0) 0.348
Diabetes mellitus (%) 16 (55.2) 29 (17.8) 0.002*
Atrial fibrillation (%) 4 (13.8) 18 (40.0) 0.020*
Dyslipidemia (%) 4 (13.8) 10 (22.2) 0.545
Current smoking (%) 11 (37.9) 17 (37.0) 0.119
Initial NIHSS 5.44.5 4.84.9 0.629
Infarct volume, cm3 20.742.6 14.221.7 0.420




Leukoaraiosis 1.31.0 1.21.2 0.700




Fibrinogen, mg/dL 360.4108.2 357.297.1 0.900
Vitamin B12, pg/mL 524.5263.4 625.2476.1 0.337
Homocysteine, mol/L 14.56.8 9.15.7 0.032*
Folate, ng/mL 6.46.2 6.42.9 0.849
Hematocrit, % 41.84.1 40.95.6 0.259
Cholesterol, mg/dL 170.534.2 184.033.9 0.101







*P0.05, Student t test or Pearson 2 test.
Table 4. Logistic Regression Findings Based on an Analysis
of the Low CFU and Intermediate CFU Groups
OR 95% CI for OR P Value
Age 0.995 0.915–1.033 0.834
HbA1c 0.548 0.317–0.907 0.032
Homocysteine 0.969 0.838–1.105 0.488
Table 5. Factors Associated With the Outgrowth Cell







Age 64.114.3 62.411.4 0.583
Hypertension (%) 11 (50.0) 30 (56.6) 0.620
Diabetes mellitus (%) 6 (27.3) 18 (34.6) 0.597
Atrial fibrillation (%) 4 (18.2) 18 (34.6) 0.179
Dyslipidemia (%) 4 (18.2) 10 (11.2) 0.916
Current smoking (%) 6 (27.3) 22 (41.5) 0.302
NIHSS on admission 2.73.0 6.05.0 0.005*
Infarct volume, cm3 7.511.7 22.538.8 0.029*




Leukoaraiosis 1.31.1 1.21.1 0.954




Fibrinogen, mg/dL 360.4115.2 357.296.1 0.456
Vitamin B12, pg/mL 699.7323.4 341.2266.0 0.707
Homocysteine, mol/L 12.55.0 11.76.2 0.331
Folate, ng/mL 6.02.9 6.53.9 0.399
Hematocrit, % 42.53.7 40.95.6 0.204
Cholesterol, mg/dL 184.530.0 176.536.2 0.329







*P0.05, Student t test.
Table 6. Logistic Regression Findings Based on an Analysis
of Patient Outgrowth Cell-Negative and -Positive Groups
OR 95% CI for OR P Value
Age 0.965 0.921–1.012 0.147
NIHSS on admission 1.289 1.026–1.621 0.029
Infarct volume 1.006 0.974–1.039 0.710
C-reactive protein 1.140 0.831–1.564 0.416
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iate analysis identified NIHSS score on admission as the only
significant independent predictor of outgrowth cell generation.
Discussion
The present study provides evidence of relationships between
the known surrogate markers of chronic vasculopathy, ie,
HbA1c and homocysteine, and the CFU level in the patients
with acute stroke. In addition, indices of neurological dam-
age, namely NIHSS and infarct volume, were found to be
significantly associated with outgrowth cell appearance. Our
results indicate that the CFU level and outgrowth cell
appearance serve as markers of accumulated vascular risk and
response to ongoing tissue damage, respectively.
We found that patients with acute stroke had lower CFUs
than healthy subjects and subjects with chronic stroke and
that the patients with LAA and SVO had much lower CFUs
than patients with CE. Our findings are consistent with a
previous report,6 which showed that EPC counts differ
significantly among acute stroke, stable stroke, and normal
control subjects. Here, we extend their observations and
suggest that CFU analysis provides an additional means of
understanding stroke pathophysiology. Endothelial cell injury
and endothelial dysfunction are predictors of the risk of
vascular events, providing stimuli for the development of
atherosclerotic plaque. The EPC dysfunction observed prom-
inently in the LAA subgroup might induce endothelial cell
dysfunction and, thus, the progression of vascular disease.
Impaired EPC function has also been correlated with a variety
of risk factors such as hypertension, diabetes mellitus, and
smoking.1,2 In the present study, a higher prevalence of
vascular risk factors in the LAA, SVO, and ICH groups than
in the CE group might lead to further reduction on CFU
levels.
EPCs are believed to augment neovascularization not only
by integrating these cells into newly developing capillaries,
but also in a paracrine fashion through the secretion of
angiogenic growth factors.21,22 However, it is not known
whether this paracrine effect of EPCs is reduced in stroke. In
the present study, we found that the EPCs of patients with
stroke were impaired in a paracrine function in in vitro
angiogenesis assays. Interestingly, abilities to form tubes
were more attenuated in the LAA and SVO groups than in the
CE group. Because this angiogenesis assay evaluates multiple
growth factors involved in blood vessel growth, our results
indicate that stroke is not only associated with the absolute
number of CFUs, but also significantly with their paracrine
functions, and that this is modulated in a stroke mechanism-
dependent manner.
We also compared the effects of clinical, radiological, and
laboratory parameters on CFU levels in the subjects with
acute stroke dichotomized into low CFU and intermediate
CFU number groups. One of the factors that may affect the
CFU levels is age.1,2 We observed an age-dependent change
in the CFU levels in the patients with acute stroke, resulting
in much lower CFU levels in aged patients. These findings
suggest that the functional activities of EPCs induced by
vascular insults decline gradually with age. On the other
hand, CFU levels were found to be related to diabetes
mellitus but not to hypertension, dyslipidemia, or smoking.
Hyperglycemia has been reported to be associated with
endothelial cell dysfunction and reduced neovascularization
in response to tissue ischemia.23,24 Preclinical and clinical
studies have convincingly described the detrimental effects of
diabetes on EPC number and function,4,25,26 and our data
confirm the findings of previous reports that diabetes impairs
EPC function. This effect of diabetes on EPC may be
mediated by an increased consumption of EPCs due to their
anchoring to diffusely damaged arteries or to a more central
impact on bone marrow. An alternative explanation for the
observed association is that the higher HbA1c levels charac-
teristic of diabetes mellitus are associated with lower CFU
levels. In a previous study, EPC number was found to be
significantly related to HbA1c and blood sugar levels in
diabetes, and improved glycemic control was found to sig-
nificantly increase EPC numbers.26 In particular, in the
present study, HbA1c level was found to be an independent
predictor of a low CFU number, which suggests that degree
of glycemic dysregulation directly affects EPC function.
Outgrowth cells were reported to arise from an unidentified
population during long-term culture.27 These cells had endo-
thelial characteristics as evidenced by their morphologies and
protein and gene expressional patterns.19,20 In the present
study, outgrowth cells were generated from most patients
with stroke, but not from the majority of control subjects.
Furthermore, indices of neurological damage, namely NIHSS
and infarct volume, were found to be significantly associated
with outgrowth cell appearance. Several studies have demon-
strated after profound injury such as myocardial infarction,
coronary artery bypass grafting, or burn injury that the
number of circulating EPCs increases significantly.11–13 It is
possible that immediate endothelial or neural damage by
stroke might induce a compensatory overproduction of pro-
genitor cells from bone marrow for damage repair.
Patients with a lower CFU number might be more vulner-
able to the effects of HbA1c or homocysteine, and more
intensive risk factor modification may be required in these
patients. However, it remains to be seen whether low CFU
levels can predict stroke. In addition, it is unknown whether
risk factor modification in patients with low EPC can increase
EPC levels. Further study is needed to determine whether
interventions that target EPC number or function can reduce
the incidence of stroke. On the other hand, the high output of
outgrowth cells observed in acute stroke during the present
study suggests that circulating EPCs may provide a means of
endogenous repair to counteract the effects of acute tissue
injury and to replace dysfunctional or damaged endothelium.
The isolation and expansion of EPCs might be particularly
useful for identifying therapeutic approaches that modify the
progression and recurrence of stroke.
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